Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Stem Cell/Bone Marrow Transplantation as Biotherapy

  • Chapter
Principles of Cancer Biotherapy

  • 107 Accesses

Abstract

It is clear that bone marrow transplantation has become a major technique in the treatment of metastatic cancer. The use of autologous bone marrow transplantation has allowed for much higher doses of chemotherapy to be given in an attempt to eliminate all of the cancer cells from the patient with the sacrifice of normal bone marrow function in the process. Autologous, cryopreserved bone marrow or peripheral blood stem cells (PBSC) can be reinfused to reconstitute stem cells and bone marrow function. This process is still dose limited by damage to the gastrointestinal tract, liver, lung, heart and other critical organs [20, 36]. Considerable progress has been made using this technique to allow dose escalation with chemotherapeutic agents. Escalation of doses to the level causing damage to secondary target organs is the current limitation of this technique.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Areman EM, Cullis H, Sacher RA, et al. Automated isolation of mononuclear cells using the Fenwall CS3000 blood cell separator. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 379–385.

    Google Scholar 

  2. Ash RC, Detrick RA, Zanjani ED. Studies of human pluripotential hemopoietic stem cells (CFU-GEMM) in vitro. Blood 1981; 58: 309–316.

    PubMed  CAS  Google Scholar 

  3. Beelen DW, Ouabeck K. Graeven U, et al. Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia. Blood 1989; 74: 1507–1516.

    PubMed  CAS  Google Scholar 

  4. Berensen RJ, Bensinger WI, Hill R, et al. Stem cell selection: clinical experience. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990:403–413.

    Google Scholar 

  5. Berensen RJ, Levitt LJ, Levy R, et al. Cellular immunoabsorption using monoclonal antibodies. Selective removal of T cells from peripheral blood and bone marrow. Transplantation 1984; 38: 136–142.

    Article  Google Scholar 

  6. Blazar BR, Quinones RR, Heinitz KJ, et al. Comparison of three techniques for the ex vivo elimination of T cells from human bone marrow. Exp Hematol 1985; 13:123–128.

    PubMed  CAS  Google Scholar 

  7. Bodger MP, Hann IM, Maclean RF, et al. Enrichment of pluripotent hemopoietic progenitor cells from human bone marrow. Blood 1984; 64: 774–779.

    PubMed  CAS  Google Scholar 

  8. Brandwine JM, Callum J, Rubinger M, et al. An Evaluation of outpatient bone marrow harvesting. J Clin Oncol 1989; 7: 648–650.

    Google Scholar 

  9. Cairo MS, Toy C, Sender L, et al. Combination chemotherapy and Verapamil to purge drug resistant leukemia cells from human bone marrow. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 47–55.

    Google Scholar 

  10. Caron PC, Scheinberg DA. Therapy of acute chronic leukemias using immunologic agents. Cancer Investigation 1996; (in press)

    Google Scholar 

  11. Cassano WF, Zaytoun AM. Specific killing of neuroblastoma cells in vitro by immunotoxins. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 217–223.

    Google Scholar 

  12. Chao NJ, Schriber JR, Grimes K, et al. Granulocyte colony-stimulating factor “mobilized” peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high dose chemotherapy. Blood 1993; 81: 2031–2035.

    PubMed  CAS  Google Scholar 

  13. Civin CI, Strauss LC, Fackler MJ, et al. Positive stem cell selection: basic science. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 387–402.

    Google Scholar 

  14. Cobbold SP, Hale G, Clark MR, et al. Purging in auto- and allografts: CAMPATH monoclonal antibodies which use human complement and other natural effector mechanisms. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990:139–154.

    Google Scholar 

  15. Coutinho LH, Testa NG, Chang J, et al. The use of cultured bone marrow cells in autologous transplantation. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990:415–433.

    Google Scholar 

  16. Cramer DV, Long GS. Lymphokine-activated killer (LAK) cell purging of bone marrow. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 125–137.

    Google Scholar 

  17. Ellis WM, Georgiou GM, Roberton DM, et al. The use of discontinuous Percoll gradients to separate populations of cells from human bone marrow and peripheral blood. J Immunol Methods 1984; 66: 9–16.

    Article  PubMed  CAS  Google Scholar 

  18. Fauser AD, Messner HA. Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neutrophilic granulocytes and erythroblasts. Blood 1979; 53: 1023–1027.

    PubMed  CAS  Google Scholar 

  19. Filipovich AH, Vallera DA, Youle RJ, et al. Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease. Lancet 1984;1:469–472.

    Article  PubMed  CAS  Google Scholar 

  20. Frei E III, Canellos GP. Dose: a critical factor in cancer chemotherapy. Am J Med 1980; 69: 585–594.

    Article  PubMed  Google Scholar 

  21. Friedrich W, Goldmann SF, Vetter U, et al. Immunoreconstitution in severe combined immunodeficiency after transplantation of HAL-hapolidentical, T-cell-depleted bone marrow. Lancet 1984; 1: 761–764.

    Article  PubMed  CAS  Google Scholar 

  22. Gartner S, Kaplan H. Long-term culture of human bone marrow cells. Proc Natl Acad Sci USA 1980; 77: 4756–4759.

    Article  PubMed  CAS  Google Scholar 

  23. Georgiou GM, Roberton DM, Ellis WM, et al. Enrichment from human bone marrow using a discontinuous Percoll gradient and soybean agglutinin in comparison with Ficoll-paque. Clin Exp Immunol 1983; 53:491–496.

    PubMed  CAS  Google Scholar 

  24. Gianni AM, Siena S, Bregni M, et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; ii: 580–585.

    Article  Google Scholar 

  25. Goodnough LT, Rudnick S, Price TH, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy N Engl J Med 1989; 321: 1163–1168.

    Article  PubMed  CAS  Google Scholar 

  26. Gordon MY, Goldman JM, Gordon-Smith EC. 4- Hydroperoxycyclophosphamide inhibits proliferation by human granulocyte-macrophage colony-forming cells. (GM-CFC) but spares more primitive progenitor cells. Leukemia Res 1985; 9: 1017–1021.

    Article  CAS  Google Scholar 

  27. Granger S, Janossy G, Francis G, et al. Elimination of Tlymphocytes from human bone marrow with monoclonal T-antibodies and cytolytic complement. Br J Haematol 1982;50:367–374.

    Article  PubMed  CAS  Google Scholar 

  28. Grant S, Howe C, Kuczynski T. Selective eradication of leukemic (L-CFU) versus normal (CFU-GM) myeloid progenitors in suspension culture utilizing ’a prolonged exposure in 1-p-D-arabinofuranosylcytosine (Ara-C) and deoxycytidine (dCyd). In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 69–77.

    Google Scholar 

  29. Grebe SC, Streilein JW. Graft-versus-host reactions: a review. Adv Immunol 1976; 22: 119–221.

    Article  PubMed  CAS  Google Scholar 

  30. Greenberg PL, Baker S, Link M, et al. Immunologic selection of hemopoietic precursor cells utilizing antibody- mediated plate binding (‘panning’) . Blood 1985; 65: 190–197.

    PubMed  CAS  Google Scholar 

  31. Gross S, Gee AP, Worthington-White DA. Transporting bone marrow for in vitro purging before autologous reinfusion. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 541–549.

    Google Scholar 

  32. Gulati S, Atzpodien J, Lemoli RM, et al. Photoradiation methods for purging autologous bone marrow grafts. In: Bone marrow purging and processing. New York: Wiley- Liss, 1990: 87–102.

    Google Scholar 

  33. Gulliya KS, Batagllino M, Matthews JL. Breast cancer and laser photoradiation therapy: an in vitro model for autologous bone marrow purging. In: Bone marrow purging and processing. NewYork: Wiley-Liss, 1990: 103–107.

    Google Scholar 

  34. Hale G, Bright S, Chumbley G, et al. Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood 1983; 62: 873–882.

    PubMed  CAS  Google Scholar 

  35. Herve P, Racadot E, Flesch M, et al. Prevention of graftversus- host disease. Elimination of T-lymphocytes from bone marrow cells by complement-dependent cytolysis with a combination of pan-T monoclonal antibodies (letter). Presse Med 1984; 13(14) 886–887.

    PubMed  CAS  Google Scholar 

  36. Herzig GP. Autologous marrow transplantation for cancer therapy. In: McCullough J, Sandler SG, eds. Advances in immunobiology, blood cell antigens, and bone marrow transplantation. New York: Alan R. Liss, 1984: 319–335.

    Google Scholar 

  37. Ho WG, Champlin RE, Feig SA, et al. Transplantation of ABH incompatible bone marrow: gravity sedimentation of donor marrow. Br J Haematol 1984; 57: 155–162.

    PubMed  CAS  Google Scholar 

  38. Kapoor N, Tutschka PJ, Copelan EA. Bone marrow purging with glucocorticoids. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 39–46.

    Google Scholar 

  39. Keating A, Toneguzzo F. Gene transfer by electroporation: a model for gene therapy. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 491–498.

    Google Scholar 

  40. Kessinger A, Armitage JO, Smith DM, et al. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989; 74: 1260–1265.

    PubMed  CAS  Google Scholar 

  41. Korngold R, Sprent J. Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complex. Immunol Rev 1983; 71: 5–29.

    Article  PubMed  CAS  Google Scholar 

  42. Krolick KA, Uhr JW, Vitetta ES. Selective killing of leukaemia cells by antibody-toxin conjugates: implications for autologous bone marrow transplantation. Nature 1982;295:604–605.

    Article  PubMed  CAS  Google Scholar 

  43. Lum LC, Seugneuret MC, Storb RF, et al. In vitro regulation of immunoglobulin synthesis after marrow transplantation. I.T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease. Blood 1981;58:431–439.

    PubMed  CAS  Google Scholar 

  44. Macklis RM. Radioisotope-mediated purging in bone marrow transplantation. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 109–123.

    Google Scholar 

  45. Martin PJ, Hansen JA. Quantitative assays for detection of residual T cells ofT-depleted human marrow. Blood 1985; 65:1134–1140.

    PubMed  CAS  Google Scholar 

  46. Martin PJ, Hansen JA, Vitetta ES. A ricin A chain-containing immunotoxin that kills human T lymphocytes in vitro. Blood 1985; 66: 908–912.

    PubMed  CAS  Google Scholar 

  47. Mclntyre EA. The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies. Clin Haematol 1986; 15: 249–267.

    Google Scholar 

  48. Metcalf D. Detection and analysis of human granulocytemonocyte precursors using semi-solid cultures. Clin Haemotol 1979; 8: 263–285.

    CAS  Google Scholar 

  49. Mills LE, Ball ED, Howell AL, et al. Efficacy of bone marrow purging in AML using monoclonal antibodies and complement. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 165–170.

    Google Scholar 

  50. Mitsuyasu RT, Chaplin RE, Ho WG, et al. Prospective randomized controlled trial of ex vivo treatment of donor bone marrow with monoclonal anti-T cell antibody and complement for prevention of graft-versus-host disease: a preliminary report. Transplant Proc 1985; 17:482–485.

    Google Scholar 

  51. Naughton BA, Jacob L, Naughton GK. A three dimensional culture system for the growth of hematopoietic cells. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990; 435–445.

    Google Scholar 

  52. Noga SJ, Wagner JE, Rowley SD, et al. Using elutriation to engineer bone marrow allografts. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 345–361.

    Google Scholar 

  53. O’Reilly RJ. Allogeneic bone marrow transplantation: current status and future directions. Blood 1983; 62: 941–964.

    PubMed  Google Scholar 

  54. Peters RH, Brandon CS, Lobelia AA, et al. Combinations of 4-dydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update. In: Bone marrow purging and processing. NewYork: Wiley-Liss, 1990: 57–68.

    Google Scholar 

  55. Poynton CH, Reading CL. Monoclonal antibodies: the possibilities for cancer therapy. Exp Biol 1984; 43: 13–33.

    PubMed  CAS  Google Scholar 

  56. Poynton CH, Reading CL, Dicke KA. In: Dicke KA, Spitzer G, Zander AR, eds. Autologous bone marrow transplantation, edited by K.A. Houston: University of Texas M.D. Anderson Hospital and Tumor Institute, 1985 : 433-437.

    Google Scholar 

  57. Prentice HG, Blacklock HA, Janossy G, et al. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone marrow transplantation for acute leukaemia. Lancet 1982; 1: 700–703.

    Article  PubMed  CAS  Google Scholar 

  58. Prentice HG, Blacklock HA, Janossy G, et al. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukae mic marrow transplant recipients. Lancet 1984; 1: 472–476.

    Article  PubMed  CAS  Google Scholar 

  59. Quinones RR, Youle RJ, Kersey JH. Anti-T cell monoclonal antibodies conjugated in ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow.J Immunol 1984; 132: 678–683.

    PubMed  CAS  Google Scholar 

  60. Rappeport JM, Dunn MG, Parkman R. T lymphocytes in the peripheral blood of bone marrow transplant recipients. Transplantation 1983; 36: 674–680.

    Article  PubMed  CAS  Google Scholar 

  61. Raso V, Ritz J, Busala M, et al. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. Cancer Res 1982; 42: 457–464.

    PubMed  CAS  Google Scholar 

  62. Rizzoli V, Mangoni L. Pharmaceutical-mediated purging with mafosfamide in acute and chronic myeloid leukemias. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 21–38.

    Google Scholar 

  63. Rodt H, Kolb JH, Netzel B, et al. Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT. Transplant Proc 1981; 13: 257–261.

    PubMed  CAS  Google Scholar 

  64. Santos GW. History of bone marrow transplantation. Clin Haematol 1983; 12:611–639.

    PubMed  CAS  Google Scholar 

  65. Santos GW. Bone marrow transplantation in leukemia. Current status. Cancer 1984; 54: 2732–2740.

    Article  PubMed  CAS  Google Scholar 

  66. Santos GW. Syngeneic or autologous graft-versus-host disease. Int J Cell Cloning 1989; 7: 92–99.

    Article  PubMed  CAS  Google Scholar 

  67. Sharp TG, Sachs DH, Fauci AS, et al. T cell depletion of human bone marrow using monoclonal antibody and complement-mediated lysis. Transplantation 1983; 35: 112–120.

    Article  PubMed  CAS  Google Scholar 

  68. Sheridan WP, Wolf M, Lusk J, et al. Granulocyte colonystimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; ii: 891–895.

    Article  Google Scholar 

  69. Sheridan WP, Begley GC, Juttner CA, et al. Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 1992; 339: 640–644.

    Article  PubMed  CAS  Google Scholar 

  70. Shpall EJ, Anderson IC, Bast RC Jr, et al. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 321–336.

    Google Scholar 

  71. Siena S, Bregni M, Brando B, et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of highdose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989; 74: 1905–1914.

    PubMed  CAS  Google Scholar 

  72. Skala JP, Rogers PCJ, Chan K-W, et al. Effect of methylprednisolone and VP-16 on acute lymphocytic leukemia cells. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 79–86.

    Google Scholar 

  73. Slavin S, Waldmann H, Or R, et al. Prevention of graftversus- host disease in allogeneic bone marrow transplantation for leukemia by T cell depletion in vitro prior to transplantation. Transplant Proc 1985; 17: 465–467.

    Google Scholar 

  74. Sparkes MC, Crist ML, Sparkes RS, et al. Gene markers in human bone marrow transplantation. Vox Sang 1977; 33:202–205.

    Article  PubMed  CAS  Google Scholar 

  75. Sullivan KM, Shulman HM, Storb R, et al. Chronic graftversus- host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267–276.

    PubMed  CAS  Google Scholar 

  76. Sullivan KM, Storb R. Allogeneic marrow transplantation. Cancer Invest 1984; 2: 27–38.

    Article  PubMed  CAS  Google Scholar 

  77. Takaue Y, Watanabe T, Kawano Y, et al. Isolation and storage of peripheral blood hematopoietic stem cells for autotransplantation into children with cancer. Blood 1989; 74: 1245–1251.

    PubMed  CAS  Google Scholar 

  78. Thomas ED. Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases. J Clin Oncol 1983; 1:517–531.

    PubMed  CAS  Google Scholar 

  79. Tong AW, Dalton WS, Tsuruo T, et al. Elimination of chemoresistant myeloma clonogenic cells from human bone marrow by monoclonal antibody and complement. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 15–164.

    Google Scholar 

  80. Treleaven JG, Kemshead JT. Removal of tumour cells from bone marrow: an evaluation of the available techniques. Hematol Oncol 1985; 3: 65–75.

    Article  PubMed  CAS  Google Scholar 

  81. Vallera DA, Quinones RR, Azemove SM, et al. Monoclonal antibody-toxin conjugates reactive against human T lymphocytes. A comparison of antibody linked to intact ricin toxin with antibody linked to ricin A chain. Transplantation. 1984;37:387–392.

    Article  PubMed  CAS  Google Scholar 

  82. Vallera DA. Uckun FM. Bone marrow purging with immunotoxins for treatment of T-cell acute lymphoblastic leukemia (T-ALL). In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 191–205.

    Google Scholar 

  83. vanRhee F, Lyn F, Cullous JO, et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematological relapse. Blood 1994; 83: 3377–3383.

    CAS  Google Scholar 

  84. Vitetta ES, Uhr JW. The potential use of immunotoxins in transplantation, cancer therapy, and immunoregulation. Transplantation 1984; 37: 535–538.

    Article  PubMed  CAS  Google Scholar 

  85. Vogler WR, Olson AC, Berdel WE, et al. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 1–20.

    Google Scholar 

  86. Waldmann H, Polliak A, Hale G, et al. Elimination of graft-versus-host disease by in vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet 1984; 2: 483–486.

    Article  PubMed  CAS  Google Scholar 

  87. Williams SF, Bitran JD, Richards JM, et al. Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 461–469.

    Google Scholar 

  88. Winter JN, Bass B, Bringman T, Nedwin G. Preclinical evaluation of immunoconjugates consisting of doxorubicin linked to complement-fixing monoclonal antibody DLC-48 for bone marrow purging of B-cell lymphomas. In: Bone marrow purging and processing. New York: Wiley-Liss, 1990: 171–183.

    Google Scholar 

  89. Witherspoon R, Lum LG, Storb R. Immunologic reconstitution after human marrow grafting. Semin Hematol 1984;21:2–10.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biological Therapy Institute Foundation, Franklin, Tennessee, USA

    Robert K. Oldham

  2. University of Missouri, Columbia, Missouri, USA

    Robert K. Oldham

Authors
  1. Robert K. Oldham
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Biological Therapy Institute Foundation, Franklin, Tennessee, USA

    Robert K. Oldham M.D. (Clinical Professor of Medicine) (Clinical Professor of Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Oldham, R.K. (1998). Stem Cell/Bone Marrow Transplantation as Biotherapy. In: Oldham, R.K. (eds) Principles of Cancer Biotherapy. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0029-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0029-5_16

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6501-6

  • Online ISBN: 978-94-009-0029-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation